Literature DB >> 12975201

Osteochondritis dissecans: Wilson's sign revisited.

Jeffrey M Conrad1, Carl L Stanitski.   

Abstract

BACKGROUND: In 1967, Wilson described a clinical sign that he thought was diagnostic of medial femoral osteochondritis dissecans. He postulated that impingement of the tibial eminence on the osteochondritic lesion caused pain and a resultant compensatory lateral rotation during gait. He described reproducing the pain by internally rotating the patient's tibia during knee extension between 90 degrees and 30 degrees of flexion and then relieving that pain by externally rotating the tibia. He correlated healing of the lesion with conversion of the sign from positive to negative.
PURPOSE: To assess the validity of Wilson's assertions. STUDY
DESIGN: Retrospective clinical and radiographic case analysis.
METHODS: Case records from 17 juvenile patients (ages 9 to 12) and 15 adolescent patients (ages 13 to 17) with medial femoral osteochondritis dissecans were reviewed for the presence or absence of Wilson's sign at initial and subsequent visits.
RESULTS: Of the 32 patients, 24 (75%) with radiographically evident osteochondritis dissecans at the initial visit had negative signs. The remaining eight patients with positive signs had conversion of the sign to negative with lesion resolution.
CONCLUSIONS: In this series, Wilson's sign was of minimal clinical diagnostic value. When positive, the sign is useful as a clinical monitor during treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12975201     DOI: 10.1177/03635465030310052301

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  11 in total

Review 1.  Osteochondritis Dissecans: Etiology, Pathology, and Imaging with a Special Focus on the Knee Joint.

Authors:  Juergen Bruns; Mathias Werner; Christian Habermann
Journal:  Cartilage       Date:  2017-06-22       Impact factor: 4.634

2.  Surgical management of osteochondritis dissecans of the knee.

Authors:  Brandon J Erickson; Peter N Chalmers; Adam B Yanke; Brian J Cole
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

3.  Surgical treatment for osteochondritis dessicans of the knee.

Authors:  Zachary Winthrop; Gregory Pinkowsky; William Hennrikus
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

Review 4.  Osteochondritis Dissecans: Current Understanding of Epidemiology, Etiology, Management, and Outcomes.

Authors:  Michael M Chau; Mikhail A Klimstra; Kelsey L Wise; Jutta M Ellermann; Ferenc Tóth; Cathy S Carlson; Bradley J Nelson; Marc A Tompkins
Journal:  J Bone Joint Surg Am       Date:  2021-06-16       Impact factor: 6.558

5.  Juvenile Osteochondritis Dissecans of the Knee: Does Magnetic Resonance Imaging Instability Correlate With the Need for Surgical Intervention?

Authors:  Simon Haeri Hendy; Darren de Sa; Kelly Ainsworth; Olufemi R Ayeni; Nicole Simunovic; Devin Peterson
Journal:  Orthop J Sports Med       Date:  2017-11-14

Review 6.  Juvenile osteochondritis dissecans (JOCD) of the knee: current concepts review.

Authors:  Javier Masquijo; Alpesh Kothari
Journal:  EFORT Open Rev       Date:  2019-05-17

7.  Unique Anatomic Feature of the Posterior Cruciate Ligament in Knees Associated With Osteochondritis Dissecans.

Authors:  Masakazu Ishikawa; Nobuo Adachi; Masahiro Yoshikawa; Atsuo Nakamae; Tomoyuki Nakasa; Yasunari Ikuta; Seiju Hayashi; Masataka Deie; Mitsuo Ochi
Journal:  Orthop J Sports Med       Date:  2016-05-27

8.  OSTEOCHONDRITIS DISSECANS OF THE KNEE: DIAGNOSIS AND TREATMENT.

Authors:  Luiz Aurélio Mestriner
Journal:  Rev Bras Ortop       Date:  2015-11-04

9.  UPDATING ON DIAGNOSIS AND TREATMENT OF CHONDRAL LESION OF THE KNEE.

Authors:  Filho Marcantonio Machado da Cunha Cavalcanti; Daniel Doca; Moisés Cohen; Mário Ferretti
Journal:  Rev Bras Ortop       Date:  2015-11-16

Review 10.  Grade I Osteochondritis Dissecans in a Young Professional Athlete.

Authors:  Vinod Kumar; Nishit Bhatnagar; Jeetendra Singh Lodhi
Journal:  Indian J Orthop       Date:  2018 Jul-Aug       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.